Glenmede Trust’s M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant MBAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,586
Closed -$56K 1368
2021
Q2
$56K Buy
+5,586
New +$55.7K ﹤0.01% 1201

Other funds holding MBAC.U

Glenmede Trust's MBAC.U Position: Q3 2021 in Review

Glenmede Trust sold out of M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant (MBAC.U) in Q3 2021, closing a stake of 5,586 shares — an estimated $56K sold.

Glenmede Trust first reported a position in MBAC.U in Q2 2021 and held it in 1 quarter. The position peaked at $56K in Q2 2021. 19 funds tracked by Wall St. Rank hold MBAC.U as of Q3 2021.

  • Glenmede Trust reported no remaining M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position as of Q3 2021 after selling out during the quarter.
  • Glenmede Trust sold 5,586 M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant shares in Q3 2021, an estimated $56K.
  • Glenmede Trust first reported a position in M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant in Q2 2021 and held it in 1 quarter.
  • Glenmede Trust's M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position peaked at $56K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant as of Q3 2021.

Based on Glenmede Trust's 13F filing for Q3 2021, filed 15 Nov 2021.